Goldman Sachs’s Molecular Templates, Inc. MTEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-606
Closed -$407K 7408
2015
Q3
$407K Buy
+606
New +$431K ﹤0.01% 5341
2015
Q2
Sell
-606
Closed -$406K 7490
2015
Q1
$406K Sell
606
-1,522
-72% -$1M ﹤0.01% 5342
2014
Q4
$1.12M Hold
2,128
﹤0.01% 4447
2014
Q3
$1.27M Buy
2,128
+936
+79% +$647K ﹤0.01% 4375
2014
Q2
$779K Sell
1,192
-235
-16% -$156K ﹤0.01% 4932
2014
Q1
$1.12M Buy
+1,427
New +$1.16M ﹤0.01% 4567

Other funds holding MTEM

Goldman Sachs's MTEM Position: Q3 2024 in Review

Goldman Sachs sold out of Molecular Templates, Inc. (MTEM) in Q3 2024, closing a stake of 15,173 shares — an estimated $17.4K sold.

Goldman Sachs first reported a position in MTEM in Q2 2013 and held it in 40 quarters. The position peaked at $1.03M in Q3 2020. 24 funds tracked by Wall St. Rank hold MTEM as of Q3 2024.

  • Goldman Sachs reported no remaining Molecular Templates, Inc. position as of Q3 2024 after selling out during the quarter.
  • Goldman Sachs sold 15,173 Molecular Templates, Inc. shares in Q3 2024, an estimated $17.4K.
  • Goldman Sachs first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 40 quarters.
  • Goldman Sachs's Molecular Templates, Inc. position peaked at $1.03M in Q3 2020.
  • 24 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2024.

Based on Goldman Sachs's 13F filing for Q3 2024, filed 14 Nov 2024.